Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

Conditions: COVID-19; SARS-CoV-2 Infection Interventions: Drug: Molnupiravir Sponsors: Serap Yavuz; MDX Klinik Ara ştırma Egitim ve Danismanlik Ltd. Sti. Active, not recruiting

https://clinicaltrials.gov/study/NCT06223932

Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

More News: COVID-19 | Research | SARS